Disorder of the intestinal microbial tissue complex after a new coronavirus infection as an interdisciplinary problem

Abstract

The occurrence of diarrhea in comorbid patients with COVID-19 infection against the background of microbiocenosis disorders may be a factor in the worse outcome of the disease. The biggest threat posed by diarrhea is dehydration. Evaluation, control and timely correction of disorders of the gastrointestinal tract, allowing to identify signs associated with dehydration, impaired water and electrolyte balance, intestinal microecology and phenomena of increased epithelial permeability. It is important to consider the risk of diarrhea in patients undergoing massive therapy for COVID-19.

On the example of a specific clinical case, the most common mistakes in managing patients with acute/persistent diarrhea are analyzed. The tactics of managing a patient with diarrheal syndrome after a COVID-19 infection has been defined and substantiated, the importance of a holistic approach to solving patient problems from the standpoint of the “one health” concept has been substantiated.

Keywords

diarrhea / rehydration therapy / microbiota / new coronavirus infection

References

[1] Xiao F, Tang M, Zheng X, et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831–1833. DOI: 10.1053/j.gastro.2020.02.055

[2] Xiao F., Tang M., Zheng X. et al. Evidence for gastrointestinal infection of SARS-CoV-2 // Gastroenterology. 2020. Vol. 158, No. 6. P. 1831–1833. DOI: 10.1053/j.gastro.2020.02.055

[3] Cheung KS, Hung IF, Chan PP, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. Gastroenterology. 2020;159(1):81–95. DOI: 10.1053/j.gastro.2020.03.065

[4] Cheung K.S., Hung I.F., Chan P.P. et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis // Gastroenterology. 2020. Vol. 159, No. 1. P. 81–95. DOI: 10.1053/j.gastro.2020.03.065

[5] Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARSCoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280e8. DOI: 10.1016/j.cell.2020.02.052

[6] Hoffmann M., Kleine-Weber H., Schroeder S. et al. SARSCoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor // Cell. 2020. Vol. 181, No. 2. P. 271–280e8. DOI: 10.1016/j.cell.2020.02.052

[7] Grinevich VB, Gubonina IV, Doshchitsin VL, et al. Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020. Cardiovascular Therapy and Prevention. 2020;19(4):2630. (In Russ.). DOI: 10.15829/1728-8800-2020-2630

[8] Гриневич В.Б., Губонина И.В., Дощицин В.Л. и др. Особенности ведения коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19). Национальный Консенсус 2020 // Кардиоваскулярная терапия и профилактика. 2020. Т. 19, № 4. С. 2630. DOI: 10.15829/1728-8800-2020-2630

[9] Grinevich VB, Kravchuk YuA, Ped VI, et al. Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientific medical society of internal medicine (RSMSIM) and the Gastroenterological Scientific Society of Russia (2nd edition). Experimental and Clinical Gastroenterology. 2021;(3):5–82. (In Russ.) DOI: 10.31146/1682-8658-ecg-187-3-5-82

[10] Гриневич В.Б., Кравчук Ю.А., Педь В.И. и др. Ведение пациентов с заболеваниями органов пищеварения в период пандемии COVID-19.Клинические рекомендации Российского научного медицинского общества терапевтов и Научного общества гастроэнтерологов России (2-е издание) // Экспериментальная и клиническая гастроэнтерология. 2021. № 3. С. 5–82. DOI: 10.31146/1682-8658-ecg-187-3-5-82

[11] Maslennikov R, Svistunov A, Ivashkin V, et al. Early viral versus late antibiotic-associated diarrhea in novel coronavirus infection. Medicine (Baltimore). 2021;100(41):e27528. DOI: 10.1097/MD.0000000000027528

[12] Maslennikov R., Svistunov A., Ivashkin V. et al. Early viral versus late antibiotic-associated diarrhea in novel coronavirus infection // Medicine (Baltimore). 2021. Vol. 100, No. 41. P. e27528. DOI: 10.1097/MD.0000000000027528

[13] Giannelli FR. Antibiotic-associated diarrhea. JAAPA. 2017;30(10):46–47. DOI: 10.1097/01.JAA.0000524721.01579.c9

[14] Giannelli F.R. Antibiotic-associated diarrhea // JAAPA. 2017. Vol. 30, No. 10. P. 46–47. DOI: 10.1097/01.JAA.0000524721.01579.c9

[15] Osadchuk MA, Svistunov AA. Antibiotic-associated diarrhea in clinical practice. Current Pediatrics. 2014;13(1):102–108. (In Russ.). DOI: 10.15690/vsp.v13i1.918

[16] Осадчук М.А., Свистунов А.А. Антибиотикоассоциированная диарея в клинической практике // Вопросы современной педиатрии. 2014. Т. 13, № 1. С. 102–108. DOI: 10.15690/vsp.v13i1.918

[17] Shlyapnikov SA, Naser NR, Batyrshin IM, et al. Theantibiotic-associated colitis is a newproblem in surgery. Bulletin of Pirogov National Medical and Surgical Center. 2020;15:138–143.(In Russ.). DOI: 10.25881/BPNMSC.2020.62.96.024

[18] Шляпников С.А., Насер Н.Р., Батыршин И.М. и др. Антибиотик-ассоциированный колит — новая проблема в хирургии // Вестник Национального медико-хирургического Центра им. Н.И. Пирогова. 2020. Т. 15. С. 138–143. DOI: 10.25881/BPNMSC.2020.62.96.024

[19] Francino MP. Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances. Front Microbiol. 2016;6:1543. DOI: 10.3389/fmicb.2015.01543

[20] Francino M.P. Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances // Front. Microbiol. 2016. Vol. 6. P. 1543. DOI: 10.3389/fmicb.2015.01543

[21] Shelygin Yu, Alyoshkin V, Suhina M, et al. Clinical recommendations of the national association of specialists for the healthcare-related infections control and the Russian association of coloproctology on diagnosis, treatment and prophylaxis of clostridium difficile-associated diarrhea (CDI). Koloproktologiya. 2018;(3):7–23. (In Russ.). DOI: 10.33878/2073-7556-2018-0-3-7-23

[22] Шелыгин Ю.А., Алёшкин В.А., Сухина М.А. и др. Клинические рекомендации национальной ассоциации специалистов по контролю инфекций, связанных с оказанием медицинской помощи, и общероссийской общественной некоммерческой организации «ассоциация колопроктологов России» по диагностике, лечению и профилактике clostridium difficile-ассоциированной диареи (CDI) // Колопроктология. 2018. № 3. С. 7–23. DOI: 10.33878/2073-7556-2018-0-3-7-23

[23] Ivashkin VT, Yushchuk ND, Mayev IV, et al. Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(5). (In Russ.)

[24] Ивашкин В.Т., Ющук Н.Д., Маев И.В. и др. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению Clostridium difficile-ассоциированной болезни // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016. Т. 26, № 5.

[25] Gu S, Chen Y, Wu Z, et al. Alterations of the gut microbiota in patients with coronavirus disease 2019 orH1N1 influenza. Clin Infect Dis. 2020;71(10):2669–2678. DOI: 10.1093/cid/ciaa709

[26] Gu S., Chen Y., Wu Z. et al. Alterations of the gut microbiota in patients with coronavirus disease 2019 orH1N1 influenza // Clin. Infect. Dis. 2020. Т. 71, № 10. С. 2669–2678. DOI: 10.1093/cid/ciaa709

[27] Simanenkov VI, Maev IV, Tkacheva ON, et al. Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus. Cardiovascular Therapy and Prevention. 2021;20(1):2758. (In Russ.). DOI: 10.15829/1728-8800-2021-2758

[28] Симаненков В.И., Маев И.В., Ткачева О.Н. и др. Синдром повышенной эпителиальной проницаемости в клинической практике. Мультидисциплинарный национальный консенсусc. // Кардиоваскулярная терапия и профилактика. 2021. Т. 20, № 1. С. 2758. DOI: 10.15829/1728-8800-2021-2758

[29] Korneva EA. Pathways of neuro-immune communication: past and present time, clinical application. Medical Immunology (Russia). 2020;22(3):405–418. (In Russ.). DOI: 10.15789/1563-0625-PON-1974

[30] Корнева Е.А. Пути взаимодействия нервной и иммунной систем: история и современность, клиническое применение // Медицинская иммунология. 2020. Т. 22, № 3. С. 405–418. DOI: 10.15789/1563-0625-PON-1974

[31] Wouters MM, Van Wanrooy S, Nguyen A, et al. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis. Gut. 2016;65(8):1279–1288. DOI: 10.1136/gutjnl-2015-309460

[32] Wouters M.M., Van Wanrooy S., Nguyen A. et al. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis // Gut. 2016. Vol. 65, No. 8. P. 1279–1288. DOI: 10.1136/gutjnl-2015-309460

[33] Molina-Torres G, Rodriguez-Arrastia M, Roman P, et al. Stress and the gut microbiota-brain axis. Behav Pharmacol. 2019;30(2 and 3-Spec Issue):187–200. DOI: 10.1097/FBP.0000000000000478

[34] Molina-Torres G., Rodriguez-Arrastia M., Roman P. et al. Stress and the gut microbiota-brain axis // Behav. Pharmacol. 2019. Vol. 30, No. 2 and3-Spec Issue. P. 187–200. DOI: 10.1097/FBP.0000000000000478

[35] Zuo T, Zhang F, Lui GCY, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944–955.e8. DOI: 10.1053/j.gastro.2020.05.048

[36] Zuo T., Zhang F., Lui G.C.Y. et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization // Gastroenterology. 2020. Vol. 159, No. 3. P. 944–955.e8. DOI: 10.1053/j.gastro.2020.05.048

RIGHTS & PERMISSIONS

Grigorovich M.S.